Dachaigh › Aillse a' Bhroinn › California › Los Angeles
Sgrùdaidhean clionaigeach Aillse a' Bhroinn ann an Los Angeles, CA
Tha 22 sgrùdaidhean airson Aillse a' Bhroinn a’ lorg phàirtichean aig làraichean ann agus timcheall air Los Angeles (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
A’ fastadhÌre 1
- University of California - Los Angeles, Los Angeles
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
A’ fastadhÌre 2/3
- USC/Norris Comprehensive Cancer Center, Los Angeles
Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
A’ fastadhÌre 3
- UCLA Health, Los Angeles
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
A’ fastadhÌre 1/2
- University of Southern California, Los Angeles
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
A’ fastadhÌre 2
- Research Site, Los Angeles
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
A’ fastadhÌre 3
- UCLA, Los Angeles
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
A’ fastadhÌre 1
- START - Los Angeles, Los Angeles
- Cedars Sinai, Los Angeles
A Phase 1/1b Study of IAM1363 in HER2 Cancers
A’ fastadhÌre 1
- USC Norris Comprehensive Cancer Center, Los Angeles
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
A’ fastadhÌre 1
- ULCA, Los Angeles
A Study of MGC026 in Participants With Advanced Solid Tumors
A’ fastadhÌre 1
- The Angeles Clinic and Research Institute, Los Angeles
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
A’ fastadhÌre 1/2
- California Research Institute, Los Angeles
- Valkyrie Clinical Trials, Los Angeles
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
A’ fastadhÌre 1
- Ronald Reagan UCLA Medical Center, Los Angeles
- The Regents of the University of California, Los Angeles
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
A’ fastadhÌre 1
- USC Norris Comprehensive Cancer Center /ID# 279603, Los Angeles
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
A’ fastadhÌre 1
- Start Lacn, Los Angeles
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
A’ fastadhÌre 2
- Research Site, Los Angeles
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
A’ fastadh
- Oncology Institute for Hope and Innovation, Los Angeles
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
A’ fastadh
- Cedars-Sinai Medical Center, Los Angeles
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
A’ fastadhÌre 1/2
- University of Southern California, Los Angeles
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
A’ fastadhÌre 1/2
- Cedars Sinai Medical Center, Los Angeles
Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
A’ fastadhÌre 4
- Cedars-Sinai Medical Center, Los Angeles
A Study of NX-1607 in Adults With Advanced Malignancies
A’ fastadhÌre 1
- University of Southern California, Los Angeles
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
A’ fastadhÌre 2
- Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
Sgrùdaidhean Aillse a' Bhroinn ann am bailtean eile
- Houston, TX42 sgrùdaidhean
- Boston, MA32 sgrùdaidhean
- New York City, NY31 sgrùdaidhean
- Nashville, TN28 sgrùdaidhean
- Baldwin Park, CA22 sgrùdaidhean
- Arlington, VA20 sgrùdaidhean
- Dallas, TX19 sgrùdaidhean
- San Antonio, TX19 sgrùdaidhean
- St. Louis, MO18 sgrùdaidhean
- Grand Rapids, MI18 sgrùdaidhean
- Washington, DC16 sgrùdaidhean
- Chicago, IL16 sgrùdaidhean
Sgrùdaidhean eile ann an Los Angeles
- Aillse Sgamhain Neo-chealla-beag87 sgrùdaidhean
- Aillse (gach seòrsa)74 sgrùdaidhean
- Aillse a' bhroilleach73 sgrùdaidhean
- Aillse Prostata61 sgrùdaidhean
- Aillse colorectal59 sgrùdaidhean
- Ailse metastatach57 sgrùdaidhean
- Cancer Ovarian50 sgrùdaidhean
- Ailseachadh nan Sgamhan45 sgrùdaidhean
- Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil42 sgrùdaidhean
- Cancer Pancreatic35 sgrùdaidhean
- Ailse Endometrial34 sgrùdaidhean
- Melanoma34 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.